Table 2.

Up-to-date antigen wise coverage at 12 months of age in study participants by allocation group

	Intervention A: Adapted Alma Sana Bracelet		Intervention B: Star Bracelet		Control
Total Number of Children, n (%)	482		482		481
At BCG	217/482	(45.0)	200/482	(41.5)	216/481	(44.9)
At Pentavalent-1	265/482	(55.0)	282/482	(58.5)	265/481	(55.1)
Pentavalent-1*	208/217	(95.8)	183/200	(91.5)	202/216	(93.5)
Pentavalent-2	445/482	(92.3)	434/482	(90.0)	432/481	(89.6)
Pentavalent-3	408/482	(84.6)	411/481	(85.4)	399/481	(83.0)
Measles-1	345/479	(72.0)	339/481	(70.5)	329/480	(68.5)

*For children enrolled at BCG; Bacille Calmette Guérin

** None of the differences are significant at p ≤ 0.05

For Pentavalent-3 and Measles-1 analysis, we have excluded the children who passed away before they were due for the relevant vaccine